![Frida Grynspan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frida Grynspan worked as Vice President of Research & Development at Pluri, Inc., Vice President of Research & Development at Gamida Cell Ltd., and Principal at Intelligenetics, Inc. She holds a doctorate degree from the University of Illinois.
| Companies | Position | End |
|---|---|---|
Intelligenetics, Inc.
 Intelligenetics, Inc. Information Technology ServicesTechnology Services Develops DNA and protein sequence analysis software | Corporate Officer/Principal | - |
| PLURI INC. | Chief Tech/Sci/R&D Officer | - |
| GAMIDA CELL LTD. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Pluri, Inc.
 Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Intelligenetics, Inc.
Intelligenetics, Inc. Information Technology ServicesTechnology Services Develops DNA and protein sequence analysis software | Technology Services |
University of Illinois
 University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
